Baird Medical Investment Holdings Limited(BDMD)

Medical - Devices · Guangzhou, GD

$0.74-0.00 (-0.52%)

Delayed quote: Oct 6, 2026, 10:11 AM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T14:15:52.268Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:15:52.268Z.

Quote observation: 2026-10-06T14:11:49.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 0.739
Unrounded diluted TTM EPS · period ending 2026-06-30: N/A

FMP input reference: 3c83d1468e5e3921618bd37e367f41e2e7287b0e28e44d51d30477b87a45d5ec

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

BDMD PE Ratio Metrics

PE RATIO

N/A

BDMD Competitors' PE Ratio

BDMD

Baird Medical Investment Holdings Limited

Current

Market Cap

$31.19M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BYSI

BeyondSpring Inc.

vs BDMD

Market Cap

$31.46M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDXH

MDxHealth S.A.

vs BDMD

Market Cap

$31.10M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIRA

MIRA Pharmaceuticals, Inc.

vs BDMD

Market Cap

$31.62M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTX

Context Therapeutics Inc.

vs BDMD

Market Cap

$32.06M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRVO

CervoMed Inc.

vs BDMD

Market Cap

$29.44M

PE Ratio

N/A

TTM Avg

876.90

3Y Avg

876.90

5Y Avg

876.90

ALGS

Aligos Therapeutics, Inc.

vs BDMD

Market Cap

$32.86M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs BDMD

Market Cap

$33.24M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BEAT

HeartBeam, Inc.

vs BDMD

Market Cap

$33.53M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRDX

GridAI Technologies Corp.

vs BDMD

Market Cap

$28.35M

PE Ratio

N/A

TTM Avg

0.40

3Y Avg

0.40

5Y Avg

0.40

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Baird Medical Investment Holdings Limited (BDMD)	$31.19M	N/A	N/A	N/A	N/A
BeyondSpring Inc. (BYSI)vs ›	$31.46M	N/A	N/A	N/A	N/A
MDxHealth S.A. (MDXH)vs ›	$31.10M	N/A	N/A	N/A	N/A
MIRA Pharmaceuticals, Inc. (MIRA)vs ›	$31.62M	N/A	N/A	N/A	N/A
Context Therapeutics Inc. (CNTX)vs ›	$32.06M	N/A	N/A	N/A	N/A
CervoMed Inc. (CRVO)vs ›	$29.44M	N/A	876.90	876.90	876.90
Aligos Therapeutics, Inc. (ALGS)vs ›	$32.86M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$33.24M	N/A	N/A	N/A	N/A
HeartBeam, Inc. (BEAT)vs ›	$33.53M	N/A	N/A	N/A	N/A
GridAI Technologies Corp. (GRDX)vs ›	$28.35M	N/A	0.40	0.40	0.40

P/E Comparison

Trailing P/E

N/A

Forward P/E

9.2

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$0.74

Forward EPS (Est.)

$0.08

Forward P/E

9.24

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

BDMD PE Ratio Metrics

BDMD Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics